CRC patients with microsatellite stable phenotypes displayed increased CD68+ macrophage infiltration and enhanced SHP2 phosphorylation than microsatellite instability-high phenotypes, suggesting inhibition of SHP2 could be a promising strategy for CRC therapy. Here, CD68 is linked to colorectal carcinoma.